VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the hiring of Dr. M. Scott Alexander as the Company’s Medical Director. He will ensure the medical integrity of Cannevert Therapeutics Ltd. cannabis research programs and develop the medical affairs strategy to support their cannabis strains currently in preclinical and clinical development.
Dr. Alexander’s primary duties will be to advise physicians and regulators on the application of Cannevert’s experimental results with specific cannabis strains to their clinical practice and public policy. He will specifically address their current concerns and need for a standardized medical cannabis product that can be dosed and delivered reliably for a consistent therapeutic effect with minimal side effects. Dr. Alexander is committed to following the principles of translational medicine and developing strong partnerships with patient advocacy groups and colleges of
... read more at: https://globenewswire.com/news-release/2017/12/08/1250137/0/en/Veritas-Hires-Medical-Director-to-Advise-Physicians-Regulators-on-the-Application-of-Cannevert-s-Experimental-Results-with-Cannabis-to-Clinical-Practice-Public-Policy.html